Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Early balding at 40 increases prostate cancer risk.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Babies who gain weight quickly, especially in the first 3 months, may start puberty earlier.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Baldness may lower the risk of testicular cancer.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Monitoring for adverse effects in clinical treatments is crucial.

Long-term diabetes is linked to lower prostate cancer risk.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.